Ric kayne suspends campaign to elect himself and george bickerstaff to athira pharma board of directors

New york--(business wire)--richard a. (ric) kayne, who together with his affiliates beneficially owns approximately 4.8% of the outstanding shares of common stock of athira pharma, inc. (nasdaq: atha) (“athira” or the “company”), today issued the following letter to athira shareholders. may 16, 2022 dear fellow shareholders, i started my campaign for change at athira pharma, inc. in february 2022, nominating myself and george bickerstaff, to the athira board of directors because i believe in th
ATHA Ratings Summary
ATHA Quant Ranking